The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversal Adherence LLC

About this trial

Most patients with glaucoma use eye drops to lower their intraocular pressure. However, poor adherence to prescribed eye drop regimens can lead to significant loss of vision-related quality of life. This study will test the iDrop Device (iD2), a device-on-cap electronic platform monitor designed to accurately track when a research participant removes an eye drop bottle cap, wirelessly communicate usage data to a database accessible to researchers, and send on-demand alerts when a medication is due. A device capable of tracking eye drop usage and sending dosage alerts will test the hypothesis that electronic reminders improve medication adherence and help research subjects improve their eye drop taking behavior. While our primary focus is on glaucoma adherence, this device could also benefit those with other chronic eye conditions requiring regular eye drop treatment, such as dry eye, corneal endothelial disease, eye infections, and uveitis.

Eligibility criteria

Qualifiers

Age ≥ 18

Taking at least one glaucoma drop daily

A history of poor adherence when taking glaucoma eye drops. This is determined as an answer of 80% or less for the following question: "Over the past month, what percentage of your drops do you think you took correctly?"

Owns a functioning smart phone with Bluetooth and cellular connectivity

Disqualifiers

Advanced cognitive impairment

Current or expected pregnancy during the study.

Trial design

Treatments tested in this trial

  • Eye drop cap monitor

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Universal Adherence LLC

Lead sponsor

National Eye Institute (NEI)

Collaborator

National Institutes of Health (NIH)

Collaborator